September 26, 2020 – APBN New Site

COVID-19 Vaccine Candidate Approved for Human Clinical Trials in Singapore

September 26, 2020 . Bioboard

LUNAR-COV19, a new COVID-19 vaccine candidate developed by Arcturus Therapeutics Holdings Inc. and Duke-NUS Medical School, could produce immunity at low doses, even only after a single...

Discovery of Key Protein Sites on the SARS-CoV-2 Virus that can Potentially Improve COVID-19 Diagnosis and Therapeutics

September 26, 2020 . Bioboard

A collaborative study among medical professionals and scientists from the National Centre for Infectious Diseases (NCID) and A*STAR’s Singapore Immunology Network (SIgN) unveiled four crucial...